Regulatory affairs consulting firms serve as the bridge between pharmaceutical and biotech sponsors and the health authorities that must approve their products before they reach patients. The work demands exceptional scientific judgment, strategic thinking about regulatory pathways, and deep knowledge of jurisdiction-specific requirements — but it also generates an enormous administrative workload that consumes consultants' time and limits the firm's capacity to take on new clients.
Two of the most time-intensive administrative functions in regulatory affairs consulting are submission dossier compilation and health authority correspondence tracking. Both are high-stakes: an incomplete dossier can trigger a refuse-to-file action from the FDA or a validation deficiency notice from the EMA, while a missed or mishandled response to a health authority question can stall a review that took years to initiate.
A regulatory affairs consulting virtual assistant handles the organizational and tracking layer of both functions, keeping consultants in a strategic role rather than a document management role.
Submission Dossier Compilation: The CTD Architecture
Pharmaceutical regulatory submissions — whether an IND, NDA, BLA, or MAA — follow the Common Technical Document (CTD) format established by ICH M4. The dossier is organized into five modules covering administrative documents, quality data, nonclinical study reports, and clinical study reports. Each module has defined sections with specific content requirements, and the complete submission can run to tens of thousands of pages across hundreds of documents.
The compilation process requires collecting documents from multiple stakeholders — the sponsor's clinical, nonclinical, CMC, and medical writing teams — verifying that each document meets the applicable format requirements (PDF bookmarks, font standards, hyperlink conventions for electronic submissions), organizing documents into the correct module and section hierarchy, and performing a completeness review against the applicable guidance documents and the eCTD technical specification.
A regulatory affairs VA manages the document collection workflow. They maintain a compilation tracker listing every required document, its owner, its due date, and its current status. They send templated reminders to document owners as deadlines approach, receive submitted documents, perform format checks against the eCTD specification checklist, and log any deficiencies for the regulatory consultant to address.
The VA also manages the submission archive — maintaining version control so that the final submission package reflects the most current approved version of each document, with earlier drafts clearly segregated. According to the FDA's Center for Drug Evaluation and Research (CDER), formatting deficiencies are among the most common reasons for refuse-to-file determinations on NDA submissions.
Health Authority Correspondence Tracking
Once a submission is accepted for review, health authority interaction becomes critical. The FDA may issue a Request for Information (RFI) or an Information Request (IR) during the review cycle. The EMA's Committee for Medicinal Products for Human Use (CHMP) may issue Day 120 and Day 180 lists of outstanding issues during the centralized procedure. National competent authorities may request supplementary data or clarifications through their own communication systems.
Each piece of health authority correspondence has a formal response deadline — and missing that deadline can result in a clock stop, a negative opinion, or withdrawal of the application. Managing correspondence across multiple active submissions for multiple clients simultaneously requires a system, not just a folder.
A VA supporting correspondence tracking maintains a master log of all open health authority queries across every active submission. The log captures the date of receipt, the issuing authority, the question reference number, the response deadline, the responsible regulatory consultant, and the current response status. Each day, the VA sends a priority digest to the project lead showing queries due within the next 10 business days and flagging any response that has not been updated in the expected drafting window.
When a response is finalized and submitted, the VA logs the submission date and confirmation, archives the response document in the submission folder, and updates the tracker status. This real-time visibility into response obligations is particularly valuable for managing client communications — the regulatory consultant can give the sponsor an accurate status report without spending time combing through email archives.
Supporting Regulatory Intelligence and Meeting Preparation
A VA can also support pre-submission meeting requests — preparing Type A, B, or C meeting request packages for FDA interactions, tracking FDA's response and scheduling confirmation, and distributing meeting briefing books to client and consultant participants. This administrative support layer extends the consulting firm's effective capacity without requiring additional senior regulatory staff.
If your regulatory affairs consulting firm needs organized, deadline-aware support for dossier compilation and health authority correspondence management, Stealth Agents provides virtual assistants trained in pharmaceutical regulatory operations.
Sources
- U.S. Food and Drug Administration, CDER. "Refuse to File Actions for NDA and BLA Submissions: Guidance for Industry." FDA.gov, 2023.
- European Medicines Agency. "Guidance on the Procedure for the Submission of Applications for Marketing Authorisation." EMA.europa.eu, 2024.
- ICH Harmonised Guideline M4: Common Technical Document for the Registration of Pharmaceuticals for Human Use. International Council for Harmonisation, 2023.